News

Study: Medicare Part D diabetes patients show better adherence with mail order

BY Alaric DeArment

IRVINE, Calif. — Medicare Part D beneficiaries showed better adherence to their oral diabetes drugs when receiving them by mail order, according to a new study.

The study, conducted on behalf of Prescription Solutions by OptumRx, the pharmacy benefit management arm of health services company Optum, and published in the Journal of Medical Economics, found that patients using mail-order pharmacy showed adherence rates of 49.7%, compared with 42.8% of those who went to retail pharmacies.

"This is the first study to show that mail service can help Medicare Part D members achieve better adherence with their diabetes medications," OptumRx CEO Jacqueline Kosecoff said. "Improving adherence has been shown to prevent the worsening of disease outcomes, decrease the use of health resources and control escalating healthcare costs."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

FDA sets review date for Bydureon

BY Allison Cerra

SAN DIEGO — The Food and Drug Administration has acknowledged the resubmission of an investigational Type 2 diabetes drug made by Amylin Pharmaceuticals, Eli Lilly and Alkermes.

The FDA has set a Jan. 28, 2012 deadline for its review of Bydureon (exenatide extended-release for injectable suspension). The drug, which first was submitted to the FDA in May 2009, was declined by the regulatory agency on two occasions; the drug makers received complete response letters in March 2010 and October 2010. Bydureon, however, received marketing authorization in the European Union in June.

"If approved, we believe Bydureon will be an important new option for type 2 diabetes patients, as the first once-weekly treatment available in the U.S.," Amylin SVP research and development Christian Weyer said. "We will continue to work with the FDA through this stage of the review process."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

APhA picks new president-elect, trustees

BY Alaric DeArment

WASHINGTON — The American Pharmacists Association has elected Steven Simenson as its president for the 2012-2013 term, the group said.

Simenson, president and managing partner of Goodrich Pharmacy, a six-store chain based in Ramsey, Minn., will succeed Jenelle Sobotka; he also was elected to a second term on the APhA’s board of trustees. Daniel Hussar of Philadelphia was elected as honorary president for 2012-2013.

In addition, the APhA elected two new members to its board of trustees: Jean-Venable Goode, of Richmond, Va.; and Daniel Buffington, of Tampa, Fla. They will serve three-year terms and will be installed at the APhA’s annual meeting in New Orleans next March, the group said.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?